Adipocyte plasma membrane lipids

Adipocyte plasma membrane lipids encompass the complex array of phospholipids, sphingolipids, and cholesterol that form the structural and functional boundary of fat cells. These lipids are not merely passive barriers but are organized into highly dynamic microdomains known as lipid rafts, which facilitate the clustering of signaling molecules such as the insulin receptor (IR) and its associated proteins (Inokuchi, 2014, PubMed). In the context of metabolic disease, alterations in the lipid composition—particularly the enrichment of gangliosides like GM3—can lead to the dissociation of the insulin receptor from these rafts, thereby impairing downstream signaling and contributing to insulin resistance (Kabayama et al., 2007, PubMed). Consequently, these lipids are considered a therapeutic focal point for treating obesity-related type 2 diabetes. Pharmacological interventions, such as the use of glucosylceramide synthase inhibitors like miglustat, aim to reduce the levels of inhibitory gangliosides within the membrane to restore insulin sensitivity (Nagafuku et al., 2015, PubMed). However, targeting these lipids presents challenges due to their ubiquitous nature and the potential for off-target effects on the membrane integrity of other cell types.

Other names

Adipocyte membrane lipidsAdipocyte lipid raftsAdipocyte surface lipids

Modulation of lipid raft composition and ganglioside levels to restore insulin receptor signaling